-
PROVIDERS
Read more
Browse our latest selection of abstracts, manuscripts, and presentations.
-
LIFE SCIENCES
LIVE WEBINAR
Optimizing research with RWD: How Lens accelerates time to insights in drug discovery.
Register now. -
PATIENTS
It's About Time
View the Tempus vision.
- RESOURCES
-
ABOUT US
View Job Postings
We’re looking for people who can change the world.
Content
-
ArticlesPatient recruitment at the speed of science
Learn how Sermonix Pharmaceuticals partnered with Tempus and its TIME network of clinical sites to accelerate patient recruitment for a phase 2 study. -
ArticlesThe promise of multimodal real-world data
In this Q&A with Dr. Hisham Hamadeh of Genmab, we explore how using multimodal RWD can help organizations solve their toughest drug development challenges. -
ArticlesNavigating biomarker validation
Attaining biomarker validation is not a one-size-fits-all process. Find out how to optimize a biomarker to increase its chance of widespread adoption. -
ArticlesGetting to the heart of multimodal data
Go behind the scenes with Tempus COO Ryan Fukushima and learn how harmonized multimodal data sources help accelerate and de-risk drug development programs. -
Case StudiesSequencing for development and commercialization
If you’re wondering how Tempus’s sequencing services can help your project move forward, consider the experiences of these four organizations, who partnered with Tempus for prospective sequencing for clinical trials, retrospective sequencing and analyses, companion diagnostic development, and sponsored testing. -
Case StudiesPowering discovery: Tempus Multimodal Database
Targeting discovery is an important frontier in the fight against pancreatic cancer. Take a look at this example of how the Tempus Multimodal Database enabled a pharmaceutical company to more quickly identify pancreatic cancer subtypes’ molecular signatures. -
Case StudiesHow to identify unmet medical need with Tempus RWD
See how Tempus RWD enabled a biopharma company to correlate biomarker expression levels to patient outcomes on SoC therapies. -
Case StudiesEnhanced biomarker discovery and design
Combining sequencing, analytics, and data licensing with Tempus allows you to uncover new insights across the research and development spectrum. This case study shows how one company made it happen. -
WebinarsThe next evolution in drug development
We spoke with Janssen’s Dr. Najat Khan to find out how the company is applying advanced AI algorithms to RWD – with groundbreaking results.
